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Regulation of the Neuronal Proteasome by Zif268 (Egr1)
Allan B. James, Ann-Marie Conway, and Brian J. Morris
Division of Neuroscience and Biomedical Systems, Institute of Biomedical and Life Sciences, West Medical Building, University of Glasgow, Glasgow G12
8QQ, United Kingdom
Most forms of neuronal plasticity are associated with induction of the transcription factor Zif268 (Egr1/Krox24/NGF-IA). In a genome-
wide scan, we obtained evidence for potential modulation of proteasome subunit and regulatory genes by Zif268 in neurons, a finding of
significance considering emerging evidence that the proteasomemodulates synaptic function. Bioinformatic analysis indicated that the
candidate proteasome Zif268 target genes had a rich concentration of putative Zif268 binding sites immediately upstream of the tran-
scriptional start sites. Regulation of the mRNAs encoding the psmb9 (Lmp2) and psme2 (PA28) proteasome subunits, along with the
proteasome-regulatory kinase serum/glucocorticoid-regulatedkinase (SGK) and theproteasome-associated antigenpeptide transporter
subunit 1 (Tap1), was confirmed after transfection of a neuronal cell line with Zif268. Conversely, these mRNAs were upregulated in
cerebral cortex tissue from Zif268 knock-out mice relative to controls, confirming that Zif268 suppresses their expression in the CNS.
Transfected Zif268 reduced the activity of psmb9, SGK, and Tap1 promoter–reporter constructs. Altered psmb9, SGK, and Tap1mRNA
levelswere also observed in an in vivomodel of neuronal plasticity involvingZif268 induction: the effect of haloperidol administration on
striatal gene expression. Consistent with these effects on proteasome gene expression, increased Zif268 expression suppressed protea-
some activity, whereas Zif268 knock-out mice exhibited elevated cortical proteasome activity. Our findings reveal that Zif268 regulates
the expressionof proteasomeand related genes inneuronal cells andprovidenewevidence that altered expressionof proteasomeactivity
after Zif268 induction may be a key component of long-lasting CNS plasticity.
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Introduction
Proteasomes are multi-subunit protein complexes that provide
themajor route of targeted protein degradation in cells. The sub-
unit composition of the proteasome is thought to be constant
across most cell types, although in immune cells, transcriptional
induction of “inducible” subunit genes, the psmb8 (Lmp7),
psmb9 (Lmp2), psmb10 (MECL-1), psme1 (PA28), and psme2
(PA28) genes, can change the subunit composition to form the
“immunoproteasome” and hence increase proteasome activity
(Harris et al., 2001; Cascio et al., 2002).
Althoughmodifications in proteasome structure and function
in the immune system have been studied intensively, little is
known regarding proteasome adaptations to serve the highly spe-
cialized and polarized characteristics of neurons. However, the
subunit composition of the proteasome varies in different brain
regions (Noda et al., 2000; Ding and Keller, 2001). Interestingly,
the pyramidal neurons of the cerebral cortex and hippocampus
show the highest proteasome levels (Mengual et al., 1996) and
express the inducible psmb9 and psmb8 subunits of the immu-
noproteasome constitutively (Diaz-Hernandez et al., 2003), link-
ing psmb8 and psmb9 to the function of these glutamatergic
neurons. Proteasome subunits are located in neuronal dendrites
(Rezvani et al., 2003), implicating the proteasome in synaptic
signaling.
The late phase of most, if not all, forms of synaptic plasticity is
dependent not only on protein synthesis (Morris, 2004) but also
on limited protein degradation. Inhibition of proteasome activity
facilitates various forms of plasticity (Obin et al., 1999; Speese et
al., 2003; Zhao et al., 2003; Juo and Kaplan, 2004). The protea-
some regulates the levels of specific proteins with important roles
in synaptic communication: NMDA receptor subunits, postsyn-
aptic density scaffolding molecules (Colledge et al., 2003; Ehlers,
2003; Pak and Sheng, 2003), and synaptic glutamate transporters
(Boehmer et al., 2003, 2004).
One of the few proteins with a confirmed role in many differ-
ent forms of plasticity is the transcription factor (TF) Zif268.
Zif268 is induced during periods of plasticity [i.e., during learn-
ing tasks or induction of long-term potentiation (LTP)] in the
hippocampus, visual or temporal cortex, and spinal cord, in di-
verse species from primates to songbirds (Cole et al., 1989; Wis-
den et al., 1990; Jarvis et al., 1998; Kaczmarek et al., 1999;Mello et
al., 2004; Morris, 2004). The threshold and duration of hip-
pocampal LTP correlates with the degree of Zif268 induction
(Richardson et al., 1992; Worley et al., 1993), and mice with
targeted disruption of the Zif268 gene show deficits in late-phase
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LTP and in a range of memory tests (Jones et al., 2001), confirm-
ing the importance of Zif268 induction for long-term plasticity.
In peripheral cells, Zif268 mediates transcriptional suppression
or induction of various genes (Cao et al., 1993; Liu et al., 1996;
Beckmann and Wilce, 1997; Thottassery et al., 1999; Bahouth et
al., 2002; Virolle et al., 2003; Zhang and Liu, 2003; Wang et al.,
2005). We have recently identified candidate target genes of
Zif268 in neurons (James et al., 2005). A remarkable finding was
that many of the genes identified encoded either components of
the proteasome or proteins with functions closely allied to the
proteasome. In this study, we test the hypothesis that the expres-
sion of proteasome subunits and functionally related genes is
regulated by Zif268.
Materials andMethods
Expression constructs.An overview of the plasmid constructs used during
this study is provided in supplemental Table 1 (available at www.jneuro-
sci.org as supplemental material). The Zif268 expression vector pZif268
has been described previously (Groot et al., 2000). As a control expres-
sion construct, an N-terminal deletion mutant (3–372 aa) of pZif268,
termed ptrZif268 (truncated Zif268), was constructed (James et al.,
2005). This construct retains the 5 and 3 noncoding DNA sequence of
the full-length Zif268 insert.
Promoter–reporter chloramphenicol acetyl transferase constructs. Func-
tional analysis of the serum/glucocorticoid-regulated kinase (SGK)
(1595 to 28), proteasome 9 subunit (psmb9) (539 to 18), and
Tap1 (566 to10) promoters [whereby1 denotes the transcription
start site (TSS)] was performed using plasmids containing the wild-type
promoters cloned upstream of the chloramphenicol acetyl transferase
(CAT) gene in pBLCAT3. The pTap1-CAT and pPsmb9-CAT con-
structs, whereby the rat Tap1/psmb9 intergenic region was subcloned in
either orientation upstream of the CAT gene, were a gift fromDr. E. Blair
(University of Leeds, Leeds, UK) (Proffitt and Blair, 1997). A region of
the SGK promoter was PCR amplified from PC12 genomic DNA using
primer pairs containing HindIII and XbaI sites, respectively, and direc-
tionally cloned into pBLCAT3 to give pSGK-CAT. Details of all vectors
used are provided in supplemental Table 1 (available at www.jneuro-
sci.org as supplemental material).
Animals and treatments. The PC12 cell culture conditions were as de-
scribed previously (James et al., 2004). Tissue corresponding to the entire
striatum was isolated from male Wistar rats (200–300 g) that had re-
ceived 1mg/kg haloperidol (Tocris, Ellisville, MO) or vehicle (1 ml/kg of
0.5% hydroxypropylmethyl polyethylene glycol carbopol934) by intra-
peritoneal injection; 6 h later, striatal tissue was dissected and RNA was
extracted as described below. Mice with targeted deletion of the Zif268
gene were a generous gift from Prof. P. Charnay (Institut National de la
Sante´ et de la Recherche Me´dicale, Paris, France) (Topilko et al., 1998).
We did not assess their behavior, but all animals were in the same behav-
ioral conditions before they were killed. The anterior portion of the
cerebral cortex (frontal cortex) incorporating prefrontal, cingulate, and
motor areas was dissected for analysis.
Transient transfections. Transient transfection of confluent PC12 cells
has been described previously (James et al., 2004, 2005). Endotoxin-free
DNA (2 g of pZif268 or ptrZif268) was combined with Lipofectamine
2000 (LF200; Invitrogen, Paisley, UK) in OPTI-MEM I medium incu-
bated at room temperature for 20 min. RNA was extracted 48 h after
transfection.
GeneChip data analysis. 3 GeneChips were used for each group. The
average difference and expression level of genes were calculated accord-
ing to absolute and comparison analysis algorithms according to Af-
fymetrix (Santa Clara, CA) protocols. Normalization was performed us-
ing BioConductor (http://biowww.dfci.harvard.edu/bioconductor/).
Significant changes in expression levels for the pZif268 transfection treat-
ment relative to the control, ptrZif268, treatment were calculated using
Significance Analysis of Microarrays (SAM) (Tusher et al., 2001) (www-
stat.stanford.edu/tibs/SAM/). SAM uses permutations of the repeated
measurements to provide an accurate estimate of the percentage of genes
identified by chance, the false discovery rate (FDR), and hence avoids the
usual problems of a large number of false positive results because of the
performance of multiple uncorrected statistical tests. The FDR was set at
a threshold of 0.05 in our analysis, so few false positive results are
anticipated.
In silico inspection of promoter regions of candidate target genes. The
programGene2Promoter (Genomatix Software,Munich, Germany) was
used to extract the promoter regions from a list of accession numbers.
Typically, a region of 1101 bp (1000 to 100) was extracted. Zif268
binds to consensus DNA sequences known as Egr response elements
(EREs). The program MatInspector (Quandt et al., 1995) was used to
locate putative EREs in a DNA sequence. Core similarity was set at the
default level of 0.75. A selection of randomly chosen genes was obtained
using the randomgene selection tool at the Regulatory SequenceAnalysis
Tools web site provided by the Service de Conformation des Macromol-
e´cules Biologiques et de Bioinformatique (l’Universite´ Libre de Brux-
elles, Bruxelles, Belgium).
Reverse transcription-PCR. Where possible, at least one of the primer
pairs used for PCR was designed to span an exon–intron boundary.
Primer sequences are provided in Table 1. RNAwas extracted fromPC12
cells, mouse frontal cortex, or rat striatum using the RNeasy Mini kit
(Qiagen, Chatsworth, CA). A single PCR cycle within the logarithmic
phase of the PCR was selected. Band intensity was normalized to the
corresponding signal for the “housekeeping” gene glyceraldehyde-3-
phosphate dehydrogenase (Gapdh), and differences between the groups
were assessed using the two-sample t test (striatal/cortical studies) and
the Mann–Whitney U test (PC12 validation study).
Reporter assays.Transfections with either pZif268 or ptrZif268 expres-
sion plasmids were performed as described above, along with a reporter
plasmid (pPsmb9-CAT, pSGK-CAT, or pTap1-CAT; 2 g per well) and
the internal reference plasmid, driving-galactosidase expression from a
cytomegalovirus (CMV) promoter, pCMV (0.5 g per well) (see sup-
Table 1. RT-PCR primer sequences used during this study
Gene targeta
Oligonucleotidesb
Gene/locus accession numberc Amplicon size (bp)
Sense Antisense
Exons Sequence 5–3 Exons Sequence 5–3
Gapdh 1 CCGCTGATGCCCCCATGTTTGTGAT 1 GGCATGTCAGATCCACAACGGATAC 24383 369
psme2 6–7 AAGTGCATTCTGGTAATCACATGGATC 10–11 GATGAAGCTCAGCATAGAAGGCTCTC 29614 304
Mouse psme2 6–7 AAGTGCATTCTGGTAATCACATGGATC 10–11 GATAAAGCTCAGCATAGAAGGCCCTC 19188 304
psmb9 1–2 AGTCCACACCGGGACAACCATCATG 5–6 CCAGAGTGATGGCGTCTGTGGTGAA 24967 497
SGK 3–4 AACCCCTCACCTCCTCCAAGTCCCTCTCA 8–9 AGGAGCGAGATACTCAGGCGTGCCACA 29517 585
Tap1 5–6 TGGACCATGAGTGTCTCGGGAATGC 9–10 CAGTTTCACCTACCTCTGTGTCATAGCCCT 24811 682
aPrimers target rat cDNA template unless otherwise denoted.
bWhere possible, at least one of the primer pairs were predicted to span an exon–intron boundary. The exon number for which a section of the primer sequence is predicted to target are denoted. For primers predicted to span exon–intron
boundaries, the portions of the primer sequence that target distinct exons are characterized by alternating type style (roman or italic/underline).
cThe Entrez Gene ID is provided. The exon–intron structure information and sequence template for primer design were also obtained from the ENSEMBL database (www.ensembl.org).
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plemental Table 1, available at www.jneurosci.org as supplemental ma-
terial). Reporter expression was assayed 48 h after transfection.
-Galactosidase activities were also determined and used to correct for
variations in transfection efficiencies. Differences between groups were
assessed using one-way ANOVA, and differences relative to control val-
ues were assessed using 95% confidence intervals of the mean and the
Wilcoxon signed rank test.
Western blotting. Polyvinylidene difluoride membranes (Invitrogen)
were blocked and probed overnight at 4°C with anti-psmb9 (1:500 dilu-
tion; Abcam, Cambridge, UK). After incubation in peroxidase-
conjugated goat anti-rabbit IgG (Jackson ImmunoResearch, West
Grove, PA), diluted to 0.08 pg/ml, and further washing, immunoreactive
bands were revealed using ECL Plus on Hyperfilm ECL (Amersham Bio-
sciences, Little Chalfont, UK). Integrative optical density readings were
obtained using NIH Image (W. Rasband, National Institutes of Health,
Bethesda, MD) as described previously (Morris, 1995; Simpson and
Morris, 2000; Conway et al., 2004), and differences relative to control
values were assessed using the Wilcoxon signed rank test.
Proteasome assay. Protein concentrations were determined using the
Bio-Rad (Hercules, CA) microprotein assay system and normalized. 20S
proteasomal activity was quantified by monitoring the accumulation of
the fluorescent cleavage product 7-amino-4-methylcoumarin (AMC)
from the synthetic proteasomal substrate Suc-Leu-Leu-Val-Tyr-
aminomethylcoumarin (LLVY-AMC; Calbiochem, La Jolla, CA). Each
whole-cell lysate (PC12 cells) or tissue extract (mouse cortex) was prein-
cubated for 2 min at 37°C with 40 M LLVY-AMC before quantification
of the fluorescent proteolysis product in a Fluoroskan Ascent microplate
fluorometer (Thermo Labsystems, Basingstoke, UK). The fluorescence
of the released AMC was measured (every 30 s for 30 min) using an
excitation wavelength of 340 nm and an emission wavelength of 450 nm.
The concentration of liberated products was calculated using a standard
curve for AMC and significance assessed by three-way ANOVA (factors:
treatment, culture and time).
Results
Microarray analysis of genes encoding proteasome subunits
and functionally related genes after overexpression of Zif268
in PC12 cells
After increased expression of Zif268 in PC12 neurons, we as-
sessed the changes in the pattern of gene expression using Af-
fymetrix GeneChips to profile a large proportion of the neuronal
transcriptome. In a previous report, we noted that a number of
proteasome and related genes were prominent in the list of puta-
tive neuronal Zif268 target genes (James et al., 2005). The protea-
some comprises a 20S core consisting of 28 subunits composed of
structural proteasome (psm)  subunits (psma1–7) and proteo-
lytic  subunits (psmb1–7), with a 19S regulator at each end
consisting of ATPase subunits (psmc1–6) and non-ATPase sub-
units (psmd1–14). In the immune system, interferon-mediated
transcriptional induction of the psme1 (PA28) and psme2
(PA28) genes replaces the 19S regulator at one or both endswith
the 11S or PA28 regulator (Cascio et al., 2002). Immune chal-
lenge also increases transcription of the inducible  subunits
psmb8, psmb9, and psmb10, which then replace the constitutive 
subunits psmb5, 6, and 7. The presence of the 11S regulator and
the psmb8 and psmb9 subunits in the immunoproteasome then
increases proteasome activity (Harris et al., 2001; Cascio et al.,
2002). Detailed analysis revealed that increased expression of
Zif268 suppressed the expression of a number of proteasome
subunit genes, including psmc4, psmb8, psmb9, psme1, and psme2
(Fig. 1a).
In addition, expression of a number of proteasome accessory
and regulatory genes was also decreased, including proteasome-
related kinases such as SGK, E2 and E3 ubiquitin ligases, which are
key intermediates in the tagging of proteins for proteasomal deg-
radation, and genes encoding components of the COP9 signalo-
some (Fig. 1b). The levels of the mRNAs derived from the three
genes encoding subunits of the proteasome-associated antigen
peptide transporter (Tap) complex,Tap1,Tap2, and tapasin, also
appeared decreased. However, the level of expression of other
proteasome subunit genes was not affected by the increased ex-
pression of Zif268 (Fig. 1c).
Figure 1. Microarray analyses of proteasome gene expression in Zif268-transfected versus
control-transfected PC12 cells. Affymetrixmicroarray analysis of proteasome and related genes
in PC12 cells after transfection with the Zif268 expression vector pZif268 (f) or the inactive
mutated Zif268 expression vector ptrZif268 (u) is shown. a, Proteasome subunit genes show-
ing significant differential expression. b, Proteasome-related genes showing significant differ-
ential expression. c, Proteasome subunit genes that didnot showsignificant differential expres-
sion, with -tubulin for comparison. Results are mean SEM. *p 0.05, **p 0.01, and
***p 0.001 versus inactive Zif268 transfection (SAM analysis; n 3).
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Bioinformatic analysis of Zif268-regulated proteasome genes
Bioinformatic analysis of gene promoters, using software trained
to identify consensus TF recognition sequences, has proved of
great use in detecting functional TF binding sites (Tullai et al.,
2004; Chowdhary et al., 2005; Kamalakaran et al., 2005; Xie et al.,
2005; Zhang et al., 2005). To assess the likelihood that the iden-
tified genes are direct targets of Zif268, we assessed the abun-
dance of consensus EREs in the genomic region 1 kb upstream of
the TSS of 24 proteasome-related genes identified as potential
Zif268 targets compared with 20 randomly selected genes (see
Materials and Methods) (Table 2), using the program MatIn-
spector (Quandt et al., 1995). These analyses revealed, in all cases,
consensus EREs in the promoter regions of the 24 proteasome-
related genes. Indeed, in many cases, multiple potential EREs
were detected (Fig. 2a, Table 2).
This is compatible with evidence that functional Zif268/Egr1
sites are generally located in proximal promoter regions. Al-
though the presence of a consensus binding site in the promoter
region does not of itself prove that the gene is a target of the TF,
this is nonetheless consistent with these genes being direct targets
of Zif268. Considering that EREs are underrepresented in pro-
moters across the entire genome (Kel-Margoulis et al., 2003; Xie
et al., 2005), there is a remarkable concentration of potential
EREs in the promoter regions of these genes.
The predicted ERE abundance was substantially greater in the
1 kb upstream regions of the proteasome genes relative to the
randomly selected genes, suggesting that this finding did not oc-
cur by chance (Fig. 2a). To complement this result, we also used
another approach to assess the representation of EREs in the
promoter regions of the proteasome-related genes identified as
Zif268 targets. Rather than looking for specified consensus TF
recognition sites in individual promoter sequences, the “overrep-
resented TF binding site prediction” method (Zheng et al., 2003)
searches, with no a prioiri assumptions, for
significantly overrepresented cis elements
in a group of sequences and performs post
hoc matches to the TRANSFAC database.
This method identified an enrichment of
Sp1 sites [P(M, t)  2.8 	 1010] and
EREs [P(M, t)  3.5 	 108] in the pro-
moter regions of the proteasome-related
genes. No enrichment of Sp1 sites or EREs
was detected in the randomly selected pro-
moter sequences.
We also assessed the distribution of the
EREs in these putative promoter regions,
because, in many known Zif268 target
genes, EREs are located close to the TSS.
We found a notable concentration of the
putative EREs immediately upstream of
the TSS from the proteasome genes (Fig.
2b). Because some proteasome genes are
thought to be regulated at the transcrip-
tional level by members of the nuclear fac-
tor B (NFB)/Rel family of TFs
(Chatterjee-Kishore et al., 1998; White-
house and Tisdale, 2003; Marques et al.,
2004), and because Zif268 is known to in-
teract with andmodulate NFB/Rel trans-
activation ability (Cogswell et al., 1997;
Chapman and Perkins, 2000), we similarly
monitored the abundance of predicted
NFB/Rel binding sites in the 1 kb up-
stream regions of the proteasome-related genes. These sites were
also enriched in the upstream regions of the proteasome genes
relative to the randomly selected genes (Fig. 2c, Table 2), al-
though, interestingly, the relative abundance of predicted EREs
was even greater than that of the NFB/Rel binding sites (Fig.
2a,c).
The TF Sp1 has also been implicated in the regulation of tran-
scription of proteasome genes, and there is considerable evidence
to suggest that many actions of Zif268 involve competition or
interaction with Sp1 (Ebert et al., 1994; Srivastava et al., 1998;
Fukada and Tonks, 2001; Davis et al., 2003; Tan et al., 2003). We
therefore assessed the association between predicted EREs and
Sp1 sites in the upstream regions of the proteasome genes. We
found that 20 of 24 proteasome-related genes (83%) contained
overlapping EREs and Sp1 sites in these upstream regions com-
pared with 2 from 20 randomly selected genes (10%). The rela-
tionship between the Sp1 sites and EREs for four prototypical
genes is shown in supplemental Fig. 1 (available at www.jneurosci.
org as supplemental material). To test the hypothesis that the
ability of Zif268 to alter the expression of these genes might in-
volve coordinate interaction between Sp1,NFB/Rel, andZif268,
we searched for possible modules of TF binding sites containing
these three motifs in close proximity (30 bp). We found that 8
from 24 proteasome genes showed the presence of one or more
copies of this module in their upstream region compared with
none of the randomly selected genes (Fig. 2d). It is thought that
NFB/Rel proteins and Zif268 can interact over larger distances
(Wright et al., 1995). Although we did not analyze more widely
separated Sp1, NFB/Rel, and Zif268 modules in detail, it was
clear that a less conservative criterion (
30 bp) would have re-
vealed the presence of this combination of motifs in many more
proteaseome gene upstream regions.
These results suggest that Zif268 may exert a previously un-
Table 2. Putative Zif268-regulated proteasome genes and randomly selected genes used for the bioinformatic
analysis
Proteasome genes ERE Sp1 NFB Randomly selected genes ERE Sp1 NFB
anapc1 2 2 0 NM_001916.2 0 1 1
cdc5-like 2 5 3 BRD4 0 4 2
cop1 6 5 1 C14orf15 0 3 2
Herc3 3 2 2 C20orf26 0 11 0
mdm2 4 5 1 DKFZp761G058 1 3 2
Nedd4 2 5 1 FLJ20343 2 1 1
Nedd8-UB1 8 7 4 HEG 0 4 2
psma5 1 8 1 KIAA1958 4 5 0
psmb8 5 4 1 LIN7C 1 2 1
psmb9/Tap1 4 6 3 LOC148003 0 1 1
psmc4 2 13 2 LOC388524 0 2 1
psme1 3 1 0 LOC388617 0 18 0
psme2 8 14 2 LOC392539 0 14 0
Rhysin2 3 2 2 LOC401352 2 3 2
SAK 3 0 0 LOC402055 1 27 0
SGK 7 9 0 MAC30 2 2 2
sgt 3 1 1 PCDHA10 0 11 0
Tap2 3 10 3 RCN2 6 1 1
tapasin 7 11 3 ZNF26 2 1 0
ubc7 5 1 1 ZNF530 1 1 1
UBE2l6 2 6 2
ubiquilin 5 4 2
ubiquitinD 2 2 1
vhl 4 3 1
The candidate Zif268-regulated proteasome genes were compared with a randomly selected set of genes (see Materials and Methods) for the number of
potential EREs, Sp1 sites, and NFB sites present in the upstream regions. For details of procedures, seeMaterials andMethods. The consensus sequences are
as follows: ERE, TGCGTRGGCGK; Sp1, NGGGGGCGGGGYN; NFB, SGGRNWTTCC. Note that bioinformatic predictions are not in themselves indicative of func-
tional significance.
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suspected regulatory control on proteasome gene expression in
neurons and could interact in some cases with the relatively well
characterized NFB/Rel and Sp1 regulatory pathways. This con-
trol appears to be exerted at multiple levels of proteasome func-
tion: on genes encoding components of the proteasome, proteins
mediating peptide export to the class I MHC, ubiquitin ligase
enzymes, and proteins involved in proteasome regulation.
Validation of the influence of Zif268 on expression of
proteasome subunit genes and proteasome-related genes
Thus far the data clearly implicated Zif268 in the coordinate reg-
ulation of a number of proteasome subunit and proteasome-
related genes. Potential regulation of proteasome subunit genes
and associated E2 and E3 ligases is striking in light of the emerg-
ing concept that altered proteasome function affects synaptic
plasticity. The altered expression of inducible proteasome sub-
units such as psmb9 and psme2, which are known to be transcrip-
tionally regulated in the immune system to alter the function of
the proteasome, is especially prominent. Potential regulation of
SGK by Zif268 is also of particular interest, because SGK protects
synaptic glutamate transporters from proteasomal degradation
(Boehmer et al., 2003, 2004; Schniepp et al., 2004) and altered
glutamate transporter levels have been suggested to contribute to
LTP andmemory (Levenson et al., 2002; Shen and Linden, 2005).
Similarly, the oligopeptides generated by proteasomal protein
digestion are transported into the endoplasmic reticulum via the
antigen transporter complex (Tap1, Tap2 and tapasin). The TAP
complex is physically associatedwith the proteasome inmany cell
types (Hwang et al., 2001), and, intriguingly, targeted deletion of
theTap1 gene inmice contributes to deficits in synaptic plasticity
(Huh et al., 2000).
Four genes involved in different stages of proteasome function
were selected for additional investigation: psmb9 and psme2,
which encode proteasome subunits known to modulate protea-
some activity; Tap1, which is physically associated with the pro-
teasome and has been implicated in synaptic plasticity; and SGK,
which regulates the access to the proteasome of certain proteins
involved in plasticity and is also itself degraded by the protea-
some. We validated the differential expression of these four can-
didate Zif268 target genes ( psmb9, psme2, SGK, and Tap1) after
Zif268 transfection of PC12 cells using reverse transcription-PCR
(RT-PCR) (Fig. 3a,b). The levels of all the mRNAs tested were
suppressed by Zif268 transfection, consistent with the results
from themicroarray experiment.We alsomonitored the levels of
psmb9 protein immunoreactivity byWestern blotting. Although
there was greater variability in the levels of protein compared
with the mRNA levels, the results suggested that the levels of
psmb9 protein were also regulated by Zif268 transfection (Fig.
3c).
The level of expression of these genes was also tested in cere-
bral cortex tissue frommice with a targeted deletion of the Zif268
gene (Zif268 knock-out mice) and wild-type control mice. The
levels of psmb9, psme2, SGK, and Tap1mRNAs were all found to
be increased in the tissue from the Zif268 knock-out mice (Fig.
4a,b). In the case of psmb9, we also tested whether this regulation
of expression at the mRNA level was mirrored by altered expres-
sion at the protein level. In cortical tissue from the Zif268 knock-
outmice, there was an increase in psmb9 protein levels relative to
wild-typemice (Fig. 4c,d).We also obtained evidence for elevated
SGK expression in the hippocampus fromZif268 knock-outmice
relative to controls (data not shown).
Assessment of ability of Zif268 to transactivate the SGK,
Tap1, and psmb9 promoters
Althougb the psme2 promoter is not well characterized, the struc-
tures of psmb9, SGK, and Tap1 promoters have been described
previously (Webster et al., 1993; Proffitt and Blair, 1997;Waldeg-
ger et al., 1998). We therefore focused on these three genes, each
of them with a potentially interesting role in synaptic plasticity.
Promoter–reporter CAT constructs for the potential Zif268 tar-
get genes [all of which contain a putative ERE site(s) in their
promoter regions] were prepared (Fig. 5a) to test the ability of
Zif268 to alter the activity of the promoters. PC12 cells were
cotransfected with these constructs and either full-length Zif268
or control, truncated Zif268. In the presence of full-length
Zif268, promoter activity was suppressed for each of the three
genes selected (Fig. 5b).
Note that although the bioinformatic analysis supports the
possibility of direct actions in each case, it should be remembered
that there is a possibility that the effects of Zif268 could be indi-
rect, reflecting the induction of other TFs by Zif268, which then
themselves act on the SGK, Tap1, and psmb9 promoters. How-
ever, whether the effects of Zif268 are direct or indirect, our re-
sults clearly show that altered expression of proteasome and re-
lated genes is likely to be a consequence of the elevated Zif268
expression that occurs during neuronal plasticity.
Zif268-regulated proteasome genes and CNS plasticity
We extended our analysis of the regulated expression of these
genes using a well characterized model of CNS plasticity, the
Figure 2. Bioinformatic analysis of candidate Zif268-regulated proteasome genes. The 1 kb
upstream regions from the putative Zif268-regulated proteasome genes were compared with
the equivalent regions from 20 randomly selected genes (see Materials and Methods and sup-
plemental Table 2, available at www.jneurosci.org as supplemental material). The numbers of
genes are shown in parentheses. a, The number of predicted EREs is significantly greater in the
proteasome genes. ***p 0.001 versus randomly selected genes (Mann–Whitney U test). b,
Frequency distribution of EREs in proteasome genes (top) and randomly selected genes (bot-
tom). EREs are concentrated immediately upstream of the TSS in the proteasome genes. c, The
number of predicted NFB binding sites is significantly greater in the proteasome genes. *p
0.05 versus randomly selected genes (Mann–Whitney U test). d, The number of predicted
NFB/Sp1/ERE modules is significantly greater in the proteasome genes. For the randomly
selected genes, no NFB/Sp1/ERE modules were detected. **p 0.001 versus 0 (Wilcoxon
test). Results are shown as mean SEM.
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response of rat striatal neurons to elevated corticostriatal activity
after D2 receptor blockade in vivo. Systemic administration of
drugs with D2 dopamine receptor antagonist properties, such as
haloperidol, increases glutamate release from corticostriatal ter-
minals and produces LTP of corticostriatal transmission (Cala-
bresi et al., 1997; Cepeda et al., 2001), with dramatic induction of
striatal Zif268 (with a peak expression of1–2 h) (Nguyen et al.,
1992; Simpson and Morris, 1994; Keefe and Gerfen, 1995). We
confirmed induction of Zif268 after haloperidol administration
(Fig. 6a). We also determined the relative expression levels of the
SGK, psmb9, and Tap1mRNAs 6 h after haloperidol administra-
tion to rats. All three genes were found to
be differentially expressed in the striatum
relative to control animals (Fig. 6b,c). In-
triguingly, although psmb9 and Tap1 were
downregulated in the striatal neurons,
SGK expression was upregulated.
Assessment of ability of Zif268 to
modify proteasome activity
Proteasome activity in transfected PC12
cells was monitored using the fluorogenic
synthetic proteasome substrate LLVY-
AMC. Generation of fluorescent AMC in
these studies was completely blocked by
the proteasome inhibitor MG132 (N-
carbobenzoxyl-Leu-Leu-leucinal) (10M)
(data not shown). It was found that full-
length Zif268 induced a small but clear de-
crease in the generation of AMC by the
proteasome relative to truncated, inactive
Zif268 (Fig. 7a,b).
Proteasome activity was similarlymon-
itored in cortical tissue from Zif268
knock-out mice (Topilko et al., 1998) and
corresponding wild-type controls. Protea-
some activity was substantially elevated in
the tissue from the Zif268 knock-out mice
(Fig. 7c,d).
Discussion
We report here the novel concept that
Zif268, which is induced during many dif-
ferent forms of neuronal plasticity, regu-
lates the expression of a subset of protea-
some genes.
The rigorous statistical analysis used
for our microarray analysis, with tight
control of the false positive rate, ensures
that the potential Zif268 targets identified
can be viewed with considerable confi-
dence.We confirmed altered expression of
four of the genes identified in Zif268-
transfected cells by RT-PCR. The magni-
tude of the change detected by RT-PCR
was very similar to that detected by themi-
croarray analysis. Consistent with the mi-
croarray analysis, these genes were all
downregulated by Zif268. When we as-
sessed the level of expression of the psmb9,
psme2, Tap1, and SGK genes in CNS tissue
from Zif268 knock-out mice, we found
that the mRNA levels were all increased
relative to wild-type mice. This is very
strong evidence confirming the conclusions from the in vitro
cells: that Zif268 is involved in suppressing the transcription of
these genes. The results are striking, because these mice exhibit
learning and memory deficits, yet this is the first demonstration
of genes that show altered CNS expression as a result of the func-
tional deletion of the Zif268 gene.
The general concept of transcriptional suppression by Zif268
is not unprecedented. In fact, the recent data fromperipheral cells
suggest that a major role of Zif268 is in suppression of gene ex-
pression (Cao et al., 1993; Beckmann and Wilce, 1997; Dinkel et
Figure 3. Validation of psmb9, psme2, Tap1, and SGK regulation by Zif268 in PC12 cells. Semiquantitative RT-PCRwas used to
determine the relative expression levels of the genes. a, Representative RT-PCR product band intensities in pZif268- and
ptrZif268-transfected PC12 cells. Note the stronger band intensities for Tap1, psmb9, SGK, and psme2 in the cells transfectedwith
the truncated Zif268 expression vector ptrZif268. b, Relative amounts of target cDNAwere determined (see Materials and Meth-
ods) 48 h after transfection. Results from five independent experiments are shown from ptrZif268 () and pZif268 (f)-
transfected cells (means SEM). *p 0.05; **p 0.01, expression levels lower in pZif268-transfected PC12 cells compared
with ptrZif268-transfected cells (Mann–WhitneyU test). c, Levels of psmb9 protein immunoreactivity (psmb9-ir) in pZif268- and
ptrZif268-transfected PC12 cells. The results suggested a corresponding regulation of protein levels.
Figure 4. Validation of psmb9, psme2, Tap1, and SGK regulation by Zif268 in Zif268 knock-outmice. Semiquantitative RT-PCR
was used to determine the relative expression levels of the genes. a, Representative RT-PCR product band intensities for tissue
from wild-type (/) and Zif268 knock-out (/) mice. b, Relative mRNA expression in cortical tissue isolated from age-
matched Zif268 wild-type () and Zif268 knock-out (f) mice. c, Western blot bands showing psmb9 immunoreactivity in
cortical tissue from wild-type (/) and Zif268 knock-out (/) mice. d, Relative amounts of psmb9 immunoreactivity in
cortical tissue isolated from age-matched Zif268wild-type () and Zif268 knock-out (f) mice. The results are normalized pixel
intensity (relative to Gapdh signal intensity) (b) or integrated band optical density (d) and are mean SEM: *p 0.05, **p
0.01, ***p 0.001, expression levels greater in knock-out mice compared with wild-type mice (Mann–Whitney U test).
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al., 1997; Thottassery et al., 1999; Fukada and Tonks, 2001; Davis
et al., 2003; Wang et al., 2005). The proteasome-related genes
monitored in this study therefore join a growing list of genes with
expression that can be suppressed by Zif268.
Analysis of the upstream genomic sequence of the genes iden-
tified revealed many consensus Zif268 binding sites within the
proximal promoter regions, clustering immediately upstream of
the TSS, as has been noted for EREs in well characterized Zif268
target genes. Proteins of the NFB/Rel family and Sp1 have been
implicated in the regulation of proteasome genes in general and
the SGK, Tap1, and psmb9 genes in particular. A significant pro-
portion of the proteasome genes showed the presence of pre-
dictedmotifs containingNFB/Rel, Sp1, and Zif268 binding sites
in close proximity. These modules are extremely unlikely to oc-
cur by chance, and hence Zif268 may modulate the transcrip-
tional response of these genes to Sp1 or NFB/Rel, as has been
noted for some other genes (Ebert et al., 1994; Cogswell et al.,
1997; Srivastava et al., 1998; Chapman and Perkins, 2000; Fukada
and Tonks, 2001; Guillemot et al., 2001; Davis et al., 2003; Tan et
al., 2003).
The ability of Zif268 directly to modulate the activity of the
psmb9, Tap1, and SGK promoters was assessed. Consistent with
the other evidence reported here, the activ-
ity of all three promoter constructs was de-
creased by the presence of transfected
Zif268.
We also tested whether these genes
were modulated in a well characterized
model of neuronal plasticity: dopamine
antagonist-induced plasticity in the stria-
tum. We found that all three genes were
significantlymodulated in striatal neurons
by haloperidol administration in vivo. In-
terestingly, although psmb9 andTap1mR-
NAs were downregulated, SGK expression
was upregulated by haloperidol treatment.
However, it has become clear that, in non-
neuronal cells, Zif268 target genes can be
downregulated by Zif268 in some cell types and upregulated in
others (Beckmann and Wilce, 1997; Copertino et al., 1997;
Huang et al., 1997). A dramatic example of this is the upregula-
tion of expression of the CBP and p300 genes in prostate cells via
Zif268 after one stimulus (serum), and downregulation via
Zif268 after another stimulus (UV) (Yu et al., 2004). This phe-
nomenon is believed to reflect cell-specific or stimulus-specific
interactions of Zif268 with other DNA-binding proteins. A sim-
ilar phenomenon is observed with other TFs such as cAMP re-
sponse element-binding protein, in which different patterns of
target gene induction are observed in different situations (Zhang
et al., 2005). Our results provide strong evidence that the reper-
toire of the downstream effects of Zif268 induction will vary in
different situations according to some other factor (e.g., the pres-
ence or absence of other TFs activated in parallel with Zif268).
However, increased expression of striatal SGK has also been
noted in other paradigms involving Zif268 induction, the delayed
response to amphetamine treatment (Gonzalez-Nicolini and
McGinty, 2002) and genetic deletion of the dopamine transporter
(Yao et al., 2004), suggesting that upregulation of SGK after
Zif268 induction may be common in striatal neurons.
Evidence implicates both SGK and Tap1 in synaptic plasticity.
SGK protects synaptic glutamate transporters from proteasomal
degradation (Boehmer et al., 2003, 2004; Schniepp et al., 2004),
and altered glutamate transporter levels have been suggested to
contribute to LTP and memory (Levenson et al., 2002; Shen and
Linden, 2005). SGK can reportedly be either upregulated or
downregulated in the rodent hippocampus after performance of
learning tasks (Donahue et al., 2002; Tsai et al., 2002), and it is
proposed that enhanced SGK expression facilitates memory con-
solidation (Tsai et al., 2002). The oligopeptides generated by pro-
teasomal protein digestion are transported into the endoplasmic
reticulum via the antigen transporter complex (Tap1, Tap2, and
tapasin), which is physically associated with the proteasome in
many cell types (Hwang et al., 2001). Intriguingly, targeted dele-
tion of the Tap1 gene in mice contributes to deficits in synaptic
plasticity (Huh et al., 2000). Hence, in both cases, there is support
for the hypothesis that regulation of these genes via Zif268 may
contribute to synaptic plasticity. The consequences of reduced
psmb9 expression for neuronal function are not clear, and it re-
mains to be determined whether altered expression of psmb9
directly affects plasticity.
Our results showing regulation of proteasome gene expres-
sion by Zif268 are consistent with the evolving concept that pro-
teasome activity is important for neuronal plasticity. The precise
role of the proteasome is controversial. On the one hand, protea-
Figure 6. Expression of Zif268-target candidate genes during in vivo neuronal plasticity. Semiquantitative RT-PCRwas used to
determine the relative expression levels of the psmb9, SGK, and Tap1genes in striatal tissue isolated fromhaloperidol-treated rats
(hal) compared with corresponding vehicle-treated controls (veh). a, Levels of striatal Zif268mRNA 30min after treatment with
vehicle () or haloperidol (f). b, Representative RT-PCR product band intensities for candidate genes expressed in striatum
tissue for haloperidol- and vehicle-treated rats. c, Relative amounts of target cDNAwere determined (seeMaterials andMethods)
6 h after treatmentwith vehicle () or haloperidol (f). The results shown aremean SEM (n 3–6). *p 0.05; **p 0.01
(two-sample t test).
Figure 5. Promoter activity of candidate Zif268 target genes. a, Plasmids used for the pro-
moter activity study (see Materials and Methods). The positions of putative ERE sites are indi-
cated (). For simplicity, lengthy regions of the SGK promoter devoid of putative EREs are
represented as dashed lines. b, Plasmids (2g) containing wild-type promoter regions of the
psmb9, SGK, and Tap1 genes were cotransfected in PC12 cells with 2 g of either pZif268
(expressing Zif268;) or, as control, ptrZif268 (expressing truncated Zif268; f). In each ex-
periment, valueswere corrected for transfection efficiency (seeMaterials andMethods). Results
from at least five independent experiments are shown (means SEM). *p 0.05 versus
control (Wilcoxon signed rank test).
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some inhibitors attenuate learning and memory (Hegde et al.,
1997; Chain et al., 1999; Lopez-Salon et al., 2002) and suppress
functional plasticity (Moss et al., 2003), whereas compromised
proteasome function has been linked with aging (Keller et al.,
2000) and with memory impairment in humans (Cooper et al.,
2004). This suggests a facilitatory role for the proteasome in plas-
ticity. In contrast, proteasome inhibition enhances neurite out-
growth, presynaptic neurotransitter release, and postsynaptic
glutamate receptor sensitivity, consistent with the proteasome
acting to suppress plasticity (Obin et al., 1999; Speese et al., 2003;
Zhao et al., 2003; Juo andKaplan, 2004). Synaptic plasticity prob-
ably depends on a precise balance between the synthesis of some
proteins and the degradation of others, as has been noted for the
guidance of growth cones in response to environmental cues
(Campbell and Holt, 2001). Regulation of proteasome genes in
the CNS by Zif268 may allow long-lasting but potentially subtle
alterations in the activity of the proteasome.
Sustained alterations in proteasome gene expression have
been associated with long-term CNS plasticity. Altered expres-
sion of a number of proteasome genes, in particular psmb9,
psme1, and SGK, has been observed in a variety of plasticitymod-
els (El-Khodor et al., 2001; Becker et al., 2003; Blalock et al., 2003;
Cirelli et al., 2004). In addition, reduction of the chymotrypsin
activity of the proteasome, as would be predicted with reduced
psmb9 levels, has been specifically linked with the modulation of
neuronal morphology (Fenteany and Schreiber, 1996). Thus, the
regulation of proteasome gene expression, and particularly the
psmb9 and psme1 genes, is likely to be of major importance for
CNS function. A speculative possibility would be that, while in-
terferon and related hormones regulate the expression of induc-
ible proteasome subunits in the immune system, this role is as-
sumed by glutamatergic activity in the CNS, via TFs including
Zif268.
Induction or repression of the proteasome subunits psmb8,
psmb9, psme1, and psme2 alters the activity of the proteasome
(Groettrup et al., 1995; Harris et al., 2001). Increased Zif268 ex-
pression suppressed overall proteasome function in PC12 cells.
The degree of inhibition was slight compared with the reductions
in psmb9 and psme2 mRNA. However, we observed high basal
proteasome activity in PC12 cells, probably because of the rela-
tively high expression of other catalytic subunits such as psmb3,
psmb5, and psmb6 (Fig. 1). Hence, the substantial Zif268-
mediated reduction in psmb9 and psme2 expression might not
greatly affect overall proteasome activity (Oberdorf et al., 2001;
Kazi et al., 2003; Berkers et al., 2005). Nevertheless, the results
indicate that Zif268 induction suppresses proteasome activity,
with the degree of suppression probably dependent on the level of
expression of other catalytic proteasome subunits in the cell at
that time.
Conversely, the absence of Zif268 in the gene-targeted mice
was associated with substantially elevated cerebral cortex protea-
some activity (Fig. 7). In the immune system, transcriptional
induction of the psmb8, psmb9, psme1, and psme2 genes enhances
proteasome activity, in the absence of any change in expression of
the constitutive  catalytic or 19S subunits (Fruh et al., 1994;
Yang et al., 1995; Hisamatsu et al., 1996). It is believed that the
psmb8 and psmb9 subunits displace the corresponding constitu-
tive  subunits, whereas the psme1 and psme2 subunits compete
reversibly with the existing constitutive 19S complex. Thus, ele-
vated proteasome activity after increased expression of the
psmb8, psmb9, psme1, and psme2 subset of proteasome subunit
genes would be predicted based on extrapolations from the im-
munoproteasome to the neuronal proteasome. Our data from
the Zif268 knock-out mice confirm the importance of Zif268 for
the regulation of CNS proteasome activity. They also raise the
interesting possibility that abnormal proteasome activity may
contribute to the impairment of late-phase LTP and the deficits
in behavioral tests of learning and memory that are observed in
these mice (Jones et al., 2001).
Overall, our discovery that Zif268 regulates the transcription
of proteasome-related genes and hence modulates the activity of
the proteasome reveals a new and previously unsuspected dimen-
sion to the mechanisms of neuronal plasticity. The regulation of
proteasome function at multiple levels provides a new insight
into the mechanisms sustaining the late phase of neuronal plas-
ticity and focusses attention particularly on protein degradation
and subsequent modification of synaptic transmission as under-
lying these enduring changes.
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